Peak Bio, Inc. (PKBO)
OTCMKTS: PKBO · Delayed Price · USD
0.0086
0.00 (0.00%)
Jun 25, 2024, 4:00 PM EDT - Market closed
Peak Bio Market Cap
Peak Bio has a market cap or net worth of $192.61 thousand as of July 3, 2024. Its market cap has decreased by -99.73% in one year.
Market Cap
192.61K
Enterprise Value
7.57M
1-Year Change
-99.73%
Ranking
n/a
Category
Stock Price
$0.01
Market Cap Chart
Since January 28, 2021, Peak Bio's market cap has decreased from $65.40M to $192.61K, a decrease of -99.71%. That is a compound annual growth rate of -94.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2023 | 51.30M | -38.93% |
| Dec 30, 2022 | 84.00M | 18.31% |
| Dec 31, 2021 | 71.00M | 8.56% |
| Jan 28, 2021 | 65.40M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 861.74B |
| Novo Nordisk | 628.28B |
| UnitedHealth Group | 458.57B |
| Johnson & Johnson | 351.45B |
| Merck & Co. | 323.49B |
| AbbVie | 293.06B |
| AstraZeneca | 238.71B |
| Novartis AG | 208.25B |